Skip to content
Monday, May 16, 2022
HealthCare Africa Magazine

Africa's No.1 Healthcare, Pharma & Biotech Industry Magazine

Africa Health & Wellness Expo ad
  • Home
  • TOPICS
    • INVESTMENTS & FUNDING
    • MERGERS & ACQUISITIONS
    • DISEASES UPDATES
    • HEALTHCARE DELIVERY
    • PHARMA MANUFACTURING
    • PEOPLE NEWS
    • CORONAVIRUS NEWS
    • REGULATORY & POLICY
  • THE MAGAZINE
    • About HealthCare Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • VIDEOS
  • COMPANY PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Lilly’s blockbuster diabetes drug wins FDA approval
  • Global Fund unveils strategy to reduce deaths from AIDS, TB, and malaria
  • FDA OKs BD's newest molecular diagnostics machine and its first test
  • FDA approves Medtronic's Onyx Frontier drug-eluting stent for treating CAD
  • Medtronic closes its deal on US$1.1B Intersect ENT acquisition
  • US NIH warrants Covid-19 technologies to WHO and MPP
  • First simulated patient treatment performed in Hospital-based BNCT Facility in Europe
  • Regulatory approvals delay CSL’s US$11.7 billion takeover of Vifor Pharma
  • Health and wellness startup FlexifyMe raises US$300K in seed round
  • Hologic secures FDA approval for Aptima CMV Quant assay, poised to challenge Abbott, Roche
You are here
  • Home
  • Sanofi

Tag: Sanofi

Sanofi tees off work on approx. US$976 million ‘factory of the future’ in France and Singapore

25 April 202225 April 2022

SINGAPORE – French pharmaceutical company, Sanofi has begun construction on the first of two so-called Evolutive Vaccine Facilities (EVFs) it is constructing with a total investment of 900 million euros…

Read More

Sanofi India appoints Rodolfo Hrosz managing director effective June 1

19 April 202219 April 2022

INDIA –Sanofi India (SIL) announced that Rodolfo Hrosz has been appointed as the Company’s new Managing Director, effective June 1, 2022, subject to regulatory approvals. He will move from his…

Read More

Sanofi and IGM team up to develop IgM antibody agonists for six targets

31 March 202231 March 2022

FRANCE – Sanofi and IGM Biosciences have formed an exclusive global partnership to create, develop, manufacture, and commercialize immunoglobulin M (IgM) antibody agonists for oncology, immunology, and inflammation targets. The…

Read More

Blackstone funds Sanofi’s new trials to develop subcutaneous form of Sarclisa

16 March 202216 March 2022

FRANCE – Sanofi and Blackstone Life Sciences have announced a risk-sharing agreement in which Blackstone Life Sciences will contribute up to €300 million (US$330 million) to fund the development of…

Read More

S&P recognizes Sanofi as one of the most sustainability-committed companies

9 March 20229 March 2022

FRANCE – Sanofi has been named one of the most sustainable companies in an ESG (Environment, Social, Governance) evaluation conducted by Standard & Poor’s Global Ratings (S&P). Sanofi received an…

Read More

DarioHealth signs US$30 million strategic agreement with Sanofi US

4 March 20224 March 2022

USA –DarioHealth Corp., a global digital therapeutics (DTx) provider, announced a US$30 million multi-year strategic agreement with Sanofi U.S., an innovative global healthcare company. The multi-year, US $30 million agreement…

Read More

Sanofi inks US$2.5 billion deal with Adagene to develop cancer antibodies

3 March 20224 March 2022

FRANCE – China’s Adagene Inc, a Nasdaq-listed innovative biopharmaceutical company focused on the discovery and development of antibody-based novel cancer immunotherapy has announced a collaboration and signed an exclusive license…

Read More

Pfizer-Valneva Lyme vaccine poised for phase 3 trials

8 February 20228 February 2022

USA – Pfizer Inc. and Valneva SE, have announced additional positive Phase 2 data for their Lyme disease vaccine candidate, VLA15, the only Lyme disease vaccine candidate currently in clinical…

Read More

FDA approves Sanofi’s Enjaymo for treatment of rare blood disease

7 February 20227 February 2022

FRANCE – The US FDA has approved Enjaymo (sutimlimab-jome) infusion to reduce the need for red blood cell transfusion due to hemolysis (red blood cell destruction) in adults with cold…

Read More

Regeneron and Sanofi pull Libtayo’s application for cervical cancer treatment

31 January 202231 January 2022

FRANCE – Regeneron Pharmaceuticals Inc and its partner Sanofi voluntarily withdrew their application to the US Food and Drug Administration to expand the use of their anti-cancer drug Libtayo in…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

Africa Health & Wellness Expo ad

Popular Posts Recent Posts

AAR Healthcare unveils new ultra-modern 140-bed capacity hospital

Ghanaian startup Yemaachi secures US$3M seed funding to advance cancer research

Lilly announces the Institute for Genetic Medicine and US$700 million investment

FDA OK’s Quantum’s Epione robot for liver cancer

Africa’s journey to healthcare independence, as fueled by effects of the ongoing pandemic

Lilly’s blockbuster diabetes drug wins FDA approval

Global Fund unveils strategy to reduce deaths from AIDS, TB, and malaria

FDA OKs BD’s newest molecular diagnostics machine and its first test

FDA approves Medtronic’s Onyx Frontier drug-eluting stent for treating CAD

Medtronic closes its deal on US$1.1B Intersect ENT acquisition

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Biogen Cancer China COVAX Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS India Investments & Funding Japan Johnson & Johnson Kenya Malaria Manufacturing Merck Mergers & Acquisitions Moderna MOH Kenya Nigeria Novartis Pfizer Pharmaceuticals Roche Sanofi Science & Technology South Africa Switzerland Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

HealthCare Africa MagazineFollow

Africa's No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa & the World

HealthCare Africa Magazine
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

Health and wellness startup @FlexifyMe raises US$300K in seed round
https://t.co/vyCRnHxiil #healthtech #innovation #health #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment #wellness #startup

Reply on Twitter 1526125167860146177Retweet on Twitter 1526125167860146177Like on Twitter 1526125167860146177Twitter 1526125167860146177
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

Regulatory approvals delay @CSL’s US$11.7 billion takeover of @ViforPharma
https://t.co/evoEdIx4d2 #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1526122199437934592Retweet on Twitter 1526122199437934592Like on Twitter 1526122199437934592Twitter 1526122199437934592
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

First simulated patient treatment performed in Hospital-based #BNCT Facility in #Europe
https://t.co/kMpazlYuAn #healthtech #innovation #health #science #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment @CosylabHQ

Reply on Twitter 1526121369926258688Retweet on Twitter 1526121369926258688Like on Twitter 1526121369926258688Twitter 1526121369926258688
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 16, 2022

The @NIH warrants Covid-19 technologies to @WHO and @MedsPatentPool
https://t.co/XZQvOsU2Cx #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1526119119074082816Retweet on Twitter 1526119119074082816Like on Twitter 1526119119074082816Twitter 1526119119074082816
HealthCareAfroHealthCare Africa Magazine@HealthCareAfro·
May 12, 2022

TPG Growth, @Temasek invest US$136 mln in @dragarwals_eye; @AdvAccountants exits
https://t.co/SfsSsS3rgp #healthtech #innovation #healthcaredelivery #healthscience #technology #Covid19 #Vaccines #pharmaceutical #manufacturing #healthcare #regulatory #policies #funding #investment

Reply on Twitter 1524666588082978816Retweet on Twitter 1524666588082978816Like on Twitter 1524666588082978816Twitter 1524666588082978816
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa magazine

Food Business Africa magazine

Food Safety Africa magazine

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.